background
acut
diarrhea
common
clinic
present
dog
effect
specif
antidiarrh
probiot
past
adpp
manag
acut
uncompl
diarrhea
dog
unknown
hypothesi
administr
adpp
contain
enterococcu
faecium
improv
clinic
outcom
acut
uncompl
diarrhea
dog
compar
placebo
anim
one
hundr
fortyeight
clientown
dog
acut
diarrhea
main
clinic
sign
method
doubleblind
placebocontrol
random
block
multicent
clinic
field
studi
conduct
primari
care
veterinari
practic
unit
kingdom
ireland
adpp
associ
better
clinic
outcom
compar
placebo
dog
acut
uncompl
diarrhea
dog
adpp
group
significantli
shorter
durat
diarrhea
adpp
median
hour
confid
interv
ci
n
placebo
median
hour
ci
n
p
rate
resolut
diarrhea
time
faster
adpp
group
placebo
group
ratio
ci
p
fewer
dog
requir
addit
medic
intervent
ami
nonimprov
worsen
adpp
group
compar
placebo
group
dog
dog
respect
rel
risk
p
ami
adpp
dog
placebo
dog
rel
risk
ci
conclus
clinic
import
adpp
may
acceler
resolut
acut
diarrhea
dog
decreas
requir
ami
k
e
w
r
acut
diarrhea
repres
common
caus
nonroutin
veterinari
visit
dog
unit
kingdom
unit
state
acut
diarrhea
constitut
shortterm
increas
fecal
water
content
consequ
fecal
fluiditi
volum
frequenc
defec
although
acut
diarrhea
tend
selflimit
repres
impair
state
health
dog
sourc
stress
inconveni
owner
potenti
zoonot
risk
recent
studi
dog
acut
diarrhea
unit
kingdom
common
treatment
dietari
modif
case
antimicrobi
treatment
case
previou
studi
report
dog
acut
diarrhea
treat
antimicrobi
despit
emerg
evid
antimicrobi
treatment
effect
dog
hemorrhag
uncompl
acut
diarrhea
consequ
acut
diarrhea
repres
consider
portion
antimicrobi
usag
veterinari
practic
recent
evid
suggest
fecal
microbiom
alter
dog
acut
diarrhea
identifi
modul
microbiom
potenti
therapeut
target
probiot
prebiot
defin
live
microorgan
confer
health
benefit
host
deliv
adequ
amount
substrat
select
promot
growth
microorgan
confer
health
benefit
respect
evid
probiot
prebiot
capabl
alter
microbiom
dog
probiot
prebiot
favor
modul
gastrointestin
health
divers
mechan
studi
investig
mechan
action
put
probiot
dog
predominantli
vitro
ex
vivo
rodent
studi
probiot
prebiot
shown
inhibit
growth
gastrointestin
pathogen
improv
gastrointestin
barrier
function
favor
modul
immun
system
extent
find
extrapol
dog
unknown
grow
evid
human
veterinari
medic
field
therapeut
potenti
probiot
prebiot
treat
prevent
acut
diarrhea
metaanalysi
studi
found
administr
probiot
shorten
durat
clinic
sign
decreas
stool
frequenc
acut
infecti
diarrhea
human
despit
lack
evid
strain
e
faecium
treatment
acut
diarrhea
dog
antidiarrh
probiot
past
adpp
contain
probiot
avail
aim
character
effect
commerci
avail
adpp
contain
e
faecium
prokolin
advanc
pka
clinic
outcom
dog
acut
diarrhea
specif
sought
identifi
whether
adpp
associ
shorter
durat
acut
diarrhea
decreas
number
dog
requir
addit
medic
intervent
ami
studi
doubleblind
placebocontrol
random
multicent
clinic
field
studi
conduct
primari
care
veterinari
practic
unit
kingdom
ireland
block
random
perform
block
size
stratifi
site
recruit
dog
includ
studi
present
veterinari
surgeon
acut
diarrhea
ownerreport
episod
diarrhea
occas
hour
present
veterinarian
caus
diarrhea
investig
dog
exclud
studi
clinic
sign
deem
unsuit
conserv
manag
attend
veterinari
surgeon
receiv
antibiot
probiot
treatment
week
day
studi
full
list
inclus
exclus
criteria
present
support
inform
ethic
approv
obtain
independ
welfar
repres
charl
river
laboratori
tranent
uk
sampl
size
case
per
group
requir
base
primari
object
identifi
differ
equal
surviv
curv
proport
dog
free
diarrhea
day
use
log
rank
test
signific
level
p
power
therefor
target
case
per
group
set
sampl
size
calcul
base
dog
adpp
group
dog
placebo
group
free
diarrhea
day
one
hundr
fortyeight
dog
fulfil
inclus
criteria
none
exclus
criteria
enrol
studi
randomli
assign
receiv
either
adpp
adpp
group
placebo
past
placebo
group
ratio
adpp
past
po
administr
contain
e
faecium
preplex
prebiot
combin
kaolin
montmorillonit
clay
psyllium
pectin
beta
glucan
pka
protexin
veterinari
somerset
uk
placebo
indistinguish
packag
appear
sensori
properti
adpp
studi
personnel
adpp
placebo
dose
accord
dog
bodi
weight
day
detail
adpp
placebo
composit
dose
regimen
found
support
inform
dog
receiv
concurr
treatment
highli
digest
diet
hill
id
topeka
kansa
place
usual
food
dog
treat
po
administ
past
diet
dog
either
complet
withdrawn
studi
maximum
day
complet
defin
passag
consecut
fece
normal
consist
primari
efficaci
criterion
durat
diarrhea
secondari
efficaci
criterion
proport
dog
withdrawn
ami
nonimprov
deterior
withdraw
ami
subsequ
treatment
decid
dog
owner
attend
veterinarian
dog
enrol
studi
process
accord
studi
procedur
describ
figur
brief
clinic
examin
perform
day
owner
dog
enrol
studi
given
adpp
placebo
syring
administ
start
immedi
diari
instruct
record
date
time
consist
fece
pass
dog
durat
studi
fecal
consist
score
perform
use
scale
hard
wateri
base
modif
nestlepurina
score
system
score
hard
firm
nestlepurina
system
combin
score
defin
normal
score
defin
diarrhea
owner
provid
text
pictori
descript
score
figur
owner
veterinarian
studi
monitor
blind
content
syring
dog
comorbid
includ
believ
neither
underli
diseas
treatment
receiv
would
expect
affect
cours
acut
diarrhea
concomit
medic
dog
receiv
studi
unrel
problem
list
support
inform
statist
analys
data
perform
use
graphpad
prism
except
dog
remov
nonimprov
deterior
diarrhea
resolv
dog
within
hour
day
dog
experienc
nonimprov
deterior
withdrawn
studi
ami
treatment
given
ami
f
g
u
r
e
summari
number
dog
recruit
exclud
part
studi
total
dog
enrol
onto
studi
diarrhea
resolv
studi
complet
dog
major
dog
fail
complet
studi
due
error
relat
dose
adpp
placebo
small
number
dog
adpp
placebo
group
withdrawn
medic
intervent
due
worsen
nonimprov
includ
efficaci
analysi
adpp
antidiarrh
probiot
past
treatment
adpp
compar
placebo
dog
acut
uncompl
diarrhea
led
decreas
durat
diarrhea
decreas
requir
ami
nonimprov
deterior
exist
evid
suggest
probiot
exert
benefici
effect
gastrointestin
health
dog
probiot
shown
acceler
resolut
nonspecif
acut
diarrhea
improv
outcom
parvovir
enter
puppi
complianc
adpp
high
compar
studi
diet
fewer
owner
involv
studi
unabl
administ
either
studi
diet
adpp
placebo
past
order
studi
accur
reflect
field
condit
dog
miss
dose
adpp
placebo
censor
analysi
provid
miss
dose
singl
day
provid
dose
interv
exceed
hour
result
interpret
context
limit
studi
design
first
assum
placebo
past
would
effect
outcom
acut
diarrhea
differ
macronutri
profil
adpp
placebo
could
influenc
durat
diarrhea
exampl
fat
content
placebo
slightli
lower
adpp
respect
lowfat
diet
commonli
recommend
dog
acut
diarrhea
effect
dietari
fat
gastrointestin
motil
possibl
undigest
fat
colon
could
exacerb
diarrhea
howev
small
differ
fat
content
adpp
placebo
deem
unlik
affect
clinic
outcom
context
total
dietari
intak
macronutri
secondli
like
durat
diarrhea
affect
manag
dog
frequenc
dog
provid
opportun
defec
outsid
like
affect
time
defec
presum
group
would
equal
affect
possibl
substanti
differ
group
manag
dog
eg
owner
group
work
away
home
could
confound
studi
find
adpp
palat
safe
dog
acut
diarrhea
dog
receiv
adpp
experienc
small
decreas
durat
diarrhea
decreas
requir
ami
deterior
nonimprov
diarrhea
adpp
repres
novel
product
exert
clinic
benefit
manag
dog
acut
diarrhea
l
nixon
employ
adm
protexin
ltd
l
rose
past
employe
adm
protexin
ltd
studi
fund
adm
protexin
ltd
manufactur
prokolin
advanc
author
declar
offlabel
use
antimicrobi
studi
approv
independ
anim
welfar
repres
object
conduct
studi
start
studi
owner
inform
studi
object
sign
owner
consent
form
studi
design
includ
pain
procedur
studi
anim
author
declar
human
ethic
approv
need
studi
sophi
l
nixon
http
